Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Parasite cell membrane phospholipid metabolism refers to the network of biochemical pathways responsible for synthesizing and remodeling the major structural lipids that compose protozoan parasite membranes—including those of malaria parasites such as Plasmodium falciparum. These processes are essential for rapid proliferation inside host erythrocytes because they support expansion and maintenance of both plasma and internal organelle membranes during replication cycles. While some lipids can be scavenged from the host environment, most pathogenic protozoa—including Plasmodium—rely heavily on de novo biosynthesis using unique enzymatic machinery not found in humans or with significant differences from human homologues. Key steps include fatty acid synthesis followed by assembly into complex glycerophospholipids via pathways like Kennedy’s pathway; critical products include phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylserine (PS). Enzymes such as CDP-choline/ethanolamine-phosphotransferase (PfCEPT) and prokaryote-type PS synthase (PfPSS) have been identified as essential components unique to parasites. These metabolic activities not only provide structural material but also play roles in protein trafficking, signal transduction, immune evasion mechanisms, nutrient acquisition from hosts, modulation of host cell membranes during invasion events, and adaptation to environmental stresses within different life cycle stages. Because these processes differ significantly between parasites and their mammalian hosts—and because they are indispensable for survival—they represent attractive targets for novel antiparasitic drug development efforts aimed at treating diseases like malaria without harming human cells.[1][2][3][4][5]
Drugs targeting this process typically act by inhibiting essential enzymes involved in de novo synthesis of major membrane phospholipids—such as blocking the formation of phosphatidylcholine or interfering with precursor uptake—thereby compromising parasite membrane integrity and survival during intraerythrocytic development[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parasite cell membrane phospholipid metabolism.